These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11271156)

  • 21. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care.
    Reinbolt RE; Shenk AM; White PH; Navari RM
    J Pain Symptom Manage; 2005 Aug; 30(2):175-82. PubMed ID: 16125033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration.
    Koshy RC; Kuriakose R; Sebastian P; Koshy C
    J Pain Palliat Care Pharmacother; 2005; 19(1):27-33. PubMed ID: 15814512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hospice physician's perspective on medications for the relief of pain and suffering.
    Maison D
    Home Healthc Nurse; 2007; 25(10):663-70. PubMed ID: 17984649
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hospice and palliative care in the outpatient department].
    Ikenaga M; Tsuneto S
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1674-9. PubMed ID: 11057318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
    Zuniga JR; Ibanez C; Kozacko M
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid use and survival at the end of life: a survey of a hospice population.
    Portenoy RK; Sibirceva U; Smout R; Horn S; Connor S; Blum RH; Spence C; Fine PG
    J Pain Symptom Manage; 2006 Dec; 32(6):532-40. PubMed ID: 17157755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative care at home: carers and medication management.
    Anderson BA; Kralik D
    Palliat Support Care; 2008 Dec; 6(4):349-56. PubMed ID: 19006589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of a palliative medicine consultation service in medical oncology.
    Homsi J; Walsh D; Nelson KA; LeGrand SB; Davis M; Khawam E; Nouneh C
    Support Care Cancer; 2002 May; 10(4):337-42. PubMed ID: 12029434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-of-life pain medication among cancer patients in hospice settings.
    Koivu L; Pölönen T; Stormi T; Salminen E
    Anticancer Res; 2014 Nov; 34(11):6581-4. PubMed ID: 25368261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center.
    Guo Y; Young BL; Hainley S; Palmer JL; Bruera E
    Arch Phys Med Rehabil; 2007 Jul; 88(7):891-5. PubMed ID: 17601470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain efficacy in home hospice patients. A longitudinal study.
    Dobratz MC; Wade R; Herbst L; Ryndes T
    Cancer Nurs; 1991 Feb; 14(1):20-6. PubMed ID: 2013048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?
    Bercovitch M; Adunsky A
    Cancer; 2004 Sep; 101(6):1473-7. PubMed ID: 15368335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of intrathecal opioids in chronic non-cancer pain.
    Roberts LJ; Finch PM; Goucke CR; Price LM
    Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical effectiveness of anti-cholinergic agents for respiratory impediment in the home palliative care setting].
    Endo M; Toya T; Matsumoto T; Maeda H; Wada T
    Gan To Kagaku Ryoho; 2008 Dec; 35 Suppl 1():19-21. PubMed ID: 20443294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
    Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.
    Zeppetella G
    J Pain Symptom Manage; 2008 May; 35(5):563-7. PubMed ID: 18258412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.